AI assistant
RELMADA THERAPEUTICS, INC. — Director's Dealing 2015
Jan 16, 2015
34465_dirs_2015-01-16_d6e545c3-1340-4224-a5f2-bcd0e81d14b4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: RELMADA THERAPEUTICS, INC. (RLMD)
CIK: 0001553643
Period of Report: 2015-01-06
Reporting Person: TRAVERSA SERGIO (Director, Chief Executive Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 497708 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Options | $0.80 | 2022-07-10 | Common Stock (677962) | Direct | |
| Options | $0.80 | 2023-09-30 | Common Stock (665750) | Direct |
Footnotes
F1: The options were granted on July 10, 2012 (the "Grant Date"). The stock options vest on the Grant Date based on the following vesting schedule: 25% of the options vest upon the Grant Date and the remaining 75% of the options, vest in equal quarterly increments over the next four (4) years, so that the last set of options shall vest in July 2016.
F2: The options were granted on September 30, 2013 (the "Grant Date"). The stock options vest on the Grant Date based on the following vesting schedule: 25% of the Options shall vest the Grant Date and the remaining 75% of the Options, shall vest in equal quarterly increments over the next four (4) years, so that the last set of options shall vest in September 2017.